Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...

Senior rheumatologists stress early intervention for arthritis to prevent joint damage, deformities, advocating lifestyle ...

NEW DELHI: Triglycerides -- the most common type of fat in blood -- could be a potential modifiable risk factor for rheumatoid arthritis in women, according to a study. Rheumatoid arthritis is a ...

An £80 blood test could help predict those who will develop Parkinson’s before they show symptoms of the disease, a new study has found. The neurodegenerative condition is one of the most ...

In a promising advancement for cancer care, doctors at AIIMS Delhi have developed a new blood test that could assist in keeping track of whether a cervical treatment is working or if the disease ...

New Delhi: A new study suggests that elevated triglyceride levels — the most common type of fat in the blood — could be a modifiable risk factor for rheumatoid arthritis (RA) in women. Published in ...

The researchers now want to explore how these blood tests could be used in everyday health care, especially for older adults who are not yet showing any symptoms. They hope that by combining these ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis of Alzheimer's disease. The immunoassay measures the ratio of ptau-217 and beta amyloid 42, two distinct ...

He has started prescribing a new kind of screening — the Shield blood test — for his patients who are hesitant to get a colonoscopy. For a decade, we've had stool collection kits like Cologuard.

Image Credit: vectorfusionart / Shutterstock Can one blood test someday inform personalized asthma treatment? Millions live with asthma, yet the symptoms vary significantly from person to person ...

The problem however is that the tests that are currently available to diagnose this rare type of blood cancer take a long time, which delays life-saving treatment. Moreover, these tests require ...